Medical News Today -
6 Nov 2013 12:00
OrSense Ltd., developer of solutions for non-invasive measurements of various blood parameters, has announced that it has received FDA clearance for its NBM-200MP, noninvasive hemoglobin (Hb) and pulse oximetry monitor. NBM-200MP belongs to OrSense's NBM-200 family of products, for the noninvasive measurement of Hb levels, enabling monitoring of anemia and hemorrhage. Currently, Hb measurements require collection of blood samples, rendering existing testing methods invasive, painful, time consum...
Share this Article